What were the primary drivers of Zoetis' revenue growth in Q1 2018?

Zoetis' revenue growth of 11% was driven by a combination of increased product volume from both in-line and new products (contributing approximately 5%), and strategic price increases (contributing approximately 2%). Foreign exchange also had a favorable impact, increasing reported revenue growth by approximately 4%.

How did the Tax Cuts and Jobs Act impact Zoetis' financial results?

The Tax Cuts and Jobs Act significantly reduced Zoetis' effective tax rate from 29.1% in Q1 2017 to 16.1% in Q1 2018. This was primarily due to the reduction in the U.S. federal corporate income tax rate from 35% to 21% effective January 1, 2018, and other adjustments related to the repatriation of foreign earnings.

What is the current status of Zoetis' financial health and liquidity?

Zoetis demonstrated a strong financial position with $1.654 billion in cash and cash equivalents as of March 31, 2018. The company maintained a healthy working capital of $3.267 billion and a current ratio of 4.27:1, indicating robust liquidity. They also had access to a $1.0 billion revolving credit facility, with no amounts drawn, and were in compliance with all financial covenants.

How did Zoetis' different business segments perform?

Both the U.S. and International segments saw revenue growth. The U.S. segment grew revenue by 5%, driven by companion animal and livestock products. The International segment showed stronger growth, with revenue up 18%, fueled by robust performance in companion animal (particularly dermatology and new products like Simparica) and livestock products, as well as a favorable foreign exchange impact.

ZTS 10-Q Quarterly Report Q1 FY2018 — Revenue, Net Income, EPS

Summary

Zoetis Inc. reported strong financial performance for the first quarter of 2018, with total revenue increasing by 11% to $1.366 billion compared to the same period in the prior year. This growth was driven by a healthy combination of increased product volume and strategic price adjustments, with operational growth contributing 7% after excluding foreign exchange impacts. Net income attributable to Zoetis Inc. saw a significant jump of 48% to $352 million, or $0.72 per diluted share, up from $0.48 in the prior year's quarter. The company's performance was bolstered by robust sales across both its livestock and companion animal segments, with international operations showing particularly strong growth of 18% in revenue. Cost of sales as a percentage of revenue decreased, indicating improved manufacturing efficiencies, which contributed to an expansion in gross margin. The effective tax rate also significantly decreased from 29.1% to 16.1%, largely due to the benefits from the Tax Cuts and Jobs Act enacted in late 2017, which lowered the U.S. federal corporate tax rate. Zoetis continues to demonstrate a solid financial position, with ample liquidity and consistent operational execution. The company's strategic investments in research and development, coupled with its focus on operational efficiencies and market leadership in animal health, position it well for continued growth and value creation for its shareholders.

Financial Highlights

52 data points

Beta

Revenue

$1.37B

0.7% Gross Margin

Net Income

$350.00M

0.3% Net Margin

EPS (Diluted)

$0.72

Total Assets

$8.69B

Cash & Equivalents

$1.65B

Free Cash Flow

$336.00M

Financial Statements

Beta

Revenue	$1.37B
Cost of Revenue	$447.00M
Gross Profit	$919.00M
SG&A Expenses	$338.00M
Operating Expenses	$947.00M
Interest Expense	$47.00M
Net Income	$350.00M
EPS (Basic)	$0.72
EPS (Diluted)	$0.72
Shares Outstanding (Basic)	485.90M
Shares Outstanding (Diluted)	489.80M

Key Highlights

1Total revenue increased 11% year-over-year to $1.366 billion, with 7% operational growth excluding foreign exchange.
2Net income attributable to Zoetis Inc. surged by 48% to $352 million, or $0.72 per diluted share, up from $0.48 in the prior year.
3International revenue grew by 18%, driven by strong performance in both livestock and companion animal segments.
4Cost of sales as a percentage of revenue improved from 36.0% to 32.7%, indicating manufacturing efficiencies.
5The effective tax rate decreased significantly from 29.1% to 16.1% due to the Tax Cuts and Jobs Act.
6The company maintained a strong cash position, with cash and cash equivalents of $1.654 billion.
7Zoetis continued its share repurchase program, with $810 million remaining under its authorization as of March 31, 2018.

Zoetis Inc. Quarterly Report for Q1 Ended Mar 31, 2018

Summary

Financial Highlights

Key Highlights

Frequently Asked Questions